<acronym id="lzrru"><strong id="lzrru"></strong></acronym>

      • <tr id="lzrru"></tr>
      2. 

      3. <td id="lzrru"></td>
    3. <object id="lzrru"><strong id="lzrru"></strong></object>
        

        1. <output id="lzrru"></output>
          <track id="lzrru"><strike id="lzrru"><tt id="lzrru"></tt></strike></track>
          <p id="lzrru"><del id="lzrru"><xmp id="lzrru"></xmp></del></p><track id="lzrru"><strike id="lzrru"></strike></track>
          

          

          
   	
    
           Chinese   English
          
            
          
          
 
          

          

          
	
          
			
	
          	  

          
 
          Home  /  R&D  /  Registration
            
 
           

          
    
          

          
  
          Registration
          Lixin Pharmaceutical has always been adhering to the global development strategy, and has already submitted 3 DMFs to FDA, obtained 3 CEP certificates, obtained 5 new drug certificates and 8 GMP certificates from NMPA. There are more than 20 products in progress as well. In addition, we have a large number of technical documents about related drug intermediates, and are always ready to provide support and services to our clients.
          

          
    
          ADD:21 Tangxi Road, Suzhou New District, Suzhou 215151 P.R. China  Copyright:Suzhou Lixin Pharmaceutical Co.,Ltd.     
          

中文无码精品A∨在线观看不卡

          <acronym id="lzrru"><strong id="lzrru"></strong></acronym>
            3. <tr id="lzrru"></tr>
            2. 

            3. <td id="lzrru"></td>
          3. <object id="lzrru"><strong id="lzrru"></strong></object>
              

              1. <output id="lzrru"></output>
                <track id="lzrru"><strike id="lzrru"><tt id="lzrru"></tt></strike></track>
                <p id="lzrru"><del id="lzrru"><xmp id="lzrru"></xmp></del></p><track id="lzrru"><strike id="lzrru"></strike></track>